RecruitingNCT06338631

Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"


Sponsor

Istituto Auxologico Italiano

Enrollment

1,000 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Overweight and obesity are increasingly prevalent worldwide. Weight excess increases the risk of in developing the metabolic syndrome, which is composed by a set of cardiometabolic risk factors such as abdominal adiposity, dyslipidemia, high blood pressure and elevated fasting glucose levels. Obesity and the metabolic syndrome are known to be risk factors for the development of chronic kidney disease. It is not clear however, whether they can be considered independent risk factors for impaired renal function and renal damage. Whereas obesity may represent an independent risk factor for renal damage, it is not clear yet if the contemporaneous presence of obesity and metabolic alterations is associated with an additional increase in the risk. It may be important to understand the relationship between obesity, metabolic syndrome and renal health, as treatment strategies may be different for the two metabolic phenotypes of obesity, i.e., metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) patients. The primary objective of this multicentre observational prospective study is to assess the relationship between metabolic phenotype and reduced renal function (glomerular filtration rate \<90 ml/min/1.73m2 or microalbuminuria 30-300 mg/24h) in a population of 1000 patients with overweight or obesity. The secondary aim is to study the association between diet quality, consumption of ultra-processed foods and indicators of reduced renal function and renal damage.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria2

  • Age between 18 and 60 years
  • BMI at least 25 kg/m2

Exclusion Criteria8

  • Pregnancy or breastfeeding
  • Diabetes mellitus
  • Renal disease
  • Systemic autoimmune diseases with possible renal involvement
  • Agonistic physical activity
  • Heart failure
  • Pharmacologcal treatment with RAAS-inhibitors, sartans, thiazide diuretics, loop diuretics
  • Urinary tract infection

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDiet

Pesonalized diet plan, devoloped according to Guidelines for dietary treatment of obesity, to be followed for a duration of 12 months


Locations(2)

Istituto Auxologico Italiano, Città Studi ICANS

Milan, Italy

Programma Infradipartimentale di Dietoterapia nel Trapianto e nell' Insufficienza Renale Cronica, DAI di Medicina Interna ad Indirizzo Specialistico, del Policlinico Federico II di Napoli

Naples, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06338631


Related Trials